Author:
O'Sullivan Catherine,Dev Kumlesh K.
Reference109 articles.
1. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis;Podbielska;Neurochem. Res.,2012
2. Sphingolipids in inflammation: pathological implications and potential therapeutic targets;Nixon;Br. J. Pharmacol.,2009
3. Sphingosine-1-phosphate signaling and its role in disease;Maceyka;Trends Cell Biol.,2012
4. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis;Kappos;N. Engl. J. Med.,2010
5. FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology;Adachi;Perspect. Med. Chem.,2008
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献